STOML2 and pancreatic neoplasm: Previous studies have suggested that STOML2 promotes the progression of multiple malignant tumors, including liver cancer [10], head and neck squamous cell carcinoma [11], ovarian cancer [12], colorectal cancer [13], and even pancreatic cancer [14].